Biomedical Engineering Reference
In-Depth Information
o N chn
ot
¼ 1
r
o
or rvN ch ð Þ b chn N chn ð N chn N chn Þþ k cm f ð r Þ C tgf N msc
d chn C tnf N chn ;
ð 15 Þ
for R c r R o : Chondrocytes are assumed not to be able to migrate, hence there
is no diffusion term in Eq. ( 15 ) and no boundary conditions need be specified.
IL-10 is secreted inside the trachea by MSCs, where it diffuses and undergoes
degradation:
þ b ilm N msc d ilk C ilk ;
o C ilk
ot
¼ 1
r
o
or
rvC ilk þ rD ilk o C ilk
or
ð 16 Þ
for R l r R o : The boundary conditions stipulate that IL-10 is secreted into the
trachea by EPCs on the lumenal surface at a rate proportional to EPC density, but
does not diffuse out of the trachea at r ¼ R o :
D ilk o C ilk
or
oC ilk
ot
ð R l ; t Þ¼ b ilk N epi ;
ð R o ; t Þ¼ 0 :
ð 17 Þ
TGF-b1 is produced by macrophages and MSC-derived chondrocytes and dif-
fuses through the domain while being degraded
o C tgf
ot
¼ 1
r
o
or
rvC tgf þ rD tgf oC tgf
or
ð 18 Þ
þ b tch N chn ð N chn N chn Þþ b tm N mac d tgf C tgf ;
for R l r R o : It is assumed that TGF-b1 is produced by the chondrocytes only
while they are proliferating i.e. until their numbers reach the carrying capacity,
hence the rate of production of TGF-b1 by these cells is assumed to be propor-
tional to the difference between the current density and the carrying capacity, N chn :
Zero-flux boundary conditions are applied to the concentration of TGF-b1 at the
lumenal and outer surfaces:
o C tgf
or
ð R l ; t Þ¼ o C tgf ð R o ; t Þ
or
¼ 0 :
ð 19 Þ
TNF-a is released by macrophages at a rate that is decreased by IL-10, diffuses
through the trachea and is degraded. Hence the equation governing the concen-
tration of TNF-a is
þ b tnf
K ti
K ti þ C ilk
o C tnf
ot
¼ 1
r
o
or
rvC tnf þ rD tnf o C tnf
or
N mac d tnf C tnf ;
ð 20 Þ
for R l r R o and with zero-flux boundary conditions at the edges of the domain:
o C tnf
or
ð R l ; t Þ¼ o C tnf
or
ð R o ; t Þ¼ 0 :
ð 21 Þ
Search WWH ::




Custom Search